Controlled Release Tacrine Delivery System for the Treatment of Alzheimer's Disease

Author： Yang Qing Williams Douglas Owusu-Ababio Godfried Ebube Nkere K. Habib Muhammad J.

ISSN： 1521-0464

Source： Drug Delivery, Vol.8, Iss.2, 2001-04, pp. : 93-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond Tacrine: Recently Developed Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease

By Unni L.K.

CNS Drugs, Vol. 10, Iss. 6, 1998-12 ,pp. : 447-460

Adis International

Access to resources Recommend Favorite

Design of New Drugs for the Treatment of Alzheimer's Disease Based on Tacrine Structure

Current Drug Targets, Vol. 14, Iss. 3, 2013-01 ,pp. : 378-397

Bentham Science Publishers

Access to resources Recommend Favorite

Swelling-controlled release system for the vaginal delivery of miconazole

By Mandal T.K.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 3, 2000-11 ,pp. : 337-343

Elsevier

Access to resources Recommend Favorite

Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

Multifunctional Tacrine Derivatives in Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 15, 2013-08 ,pp. : 1771-1786

Bentham Science Publishers

Access to resources Recommend Favorite